Kwon Dae Young, Hong Sang Mee, Ahn Il Sung, Kim Young Suk, Shin Dong Wha, Park Sunmin
Korean Food Research Institutes, Sungnam, Korea.
Nutrition. 2009 Jul-Aug;25(7-8):790-9. doi: 10.1016/j.nut.2008.12.006. Epub 2009 Feb 28.
Red pepper and soybeans have been reported to modulate energy and glucose metabolism. However, the antidiabetic effect of kochujang, the fermented product of red pepper plus soybeans, has not been studied. We examined whether kochujang affected insulin secretion from beta-cells and/or peripheral insulin resistance in 90% pancreatectomized diabetic rats fed high-fat diets.
Diabetic rats consumed a high-fat diet containing two different kinds of 5% kochujang powder or the equivalent amount of nutrients for 8 wk. Two types of kochujang were made through the fermentation of two different kinds of meju (soybeans), red peppers, glutinous rice, and malts. Meju was produced by fermenting soybeans in a traditional method (TMK) or in a more modern method in which soybeans are inoculated with Bacillus subtilus and Aspergillus sojae (MMK).
TMK and MMK decreased body weight, visceral fat, and serum leptin levels without modulating caloric intake in diabetic rats compared with the control. TMK and MMK also improved glucose tolerance by enhancing insulin sensitivity but did not potentiate glucose-stimulated insulin secretion. The improvement in hepatic insulin sensitivity caused by TMK and MMK was explained by the potentiated phosphorylation of signal transducer and activator of transcription-3 --> adenosine monophosphate kinase --> acetyl-coenzyme A carboxylase and decreased phosphoenolpyruvate carboxykinase expression. Kochujang diets reduced hepatic glucose output and triacylglycerol accumulation and increased glycogen storage.
The combination of red pepper and fermented soybeans in kochujang improves glucose homeostasis by reducing insulin resistance, not by enhancing beta-cell function, in diabetic rats. The improvement is associated with decreased hepatic fat storage by the activation of adenosine monophosphate kinase.
据报道,红辣椒和大豆可调节能量及葡萄糖代谢。然而,红辣椒加大豆的发酵产物——韩式辣椒酱的抗糖尿病作用尚未得到研究。我们研究了在喂食高脂饮食的90%胰腺切除糖尿病大鼠中,韩式辣椒酱是否会影响β细胞的胰岛素分泌和/或外周胰岛素抵抗。
糖尿病大鼠食用含两种不同5%韩式辣椒酱粉末或等量营养素的高脂饮食,持续8周。两种韩式辣椒酱是通过两种不同的豆酱(大豆)、红辣椒、糯米和麦芽发酵制成的。豆酱采用传统方法(TMK)或更现代的方法(在大豆中接种枯草芽孢杆菌和酱油曲霉,即MMK)发酵制成。
与对照组相比,TMK和MMK可降低糖尿病大鼠的体重、内脏脂肪和血清瘦素水平,且不影响热量摄入。TMK和MMK还通过增强胰岛素敏感性改善了葡萄糖耐量,但并未增强葡萄糖刺激的胰岛素分泌。TMK和MMK引起的肝脏胰岛素敏感性改善可通过信号转导子和转录激活子-3→腺苷单磷酸激酶→乙酰辅酶A羧化酶磷酸化增强及磷酸烯醇式丙酮酸羧激酶表达降低来解释。韩式辣椒酱饮食可降低肝脏葡萄糖输出和三酰甘油蓄积,并增加糖原储存。
在糖尿病大鼠中,韩式辣椒酱中的红辣椒和发酵大豆组合通过降低胰岛素抵抗而非增强β细胞功能来改善葡萄糖稳态。这种改善与通过激活腺苷单磷酸激酶减少肝脏脂肪储存有关。